“Very High Risk of Stroke after Vaccines with Concurrent Covid”. Alert by Atlanta’s University study confirms the CDC-FDA one
by Fabio Giuseppe Carlo Carisio
All linked Gospa News Italian articles can be read in English with machine translation available
«Concurrent COVID-19 infection had the strongest association with early ischemic and hemorrhagic stroke after first dose COVID-19 vaccination. The Ad26.COV2.S vaccine was associated with a higher risk of early post-vaccination ischemic stroke than BNT162b2».
Translating the pharmacological code into names and companies: the adenoviral vector Jcovden (formerly COVID-19 Vaccine Janssen) of Janssen (Johnson & Johnson), in this pathology, is therefore even more dangerous than the mRNA biotechnology of Pfizer-Biontech’s Comirnaty vaccine.
The study published in pre-print (subject to revision) on the MedRxiv medical site which enjoys the partnership of the prestigious British scientific journal BMJ by some researchers at Emory University Hospital in Atlanta (Georgia, USA) fully confirms the warning of safety launched by the CDC (Centers for Disease Control and Prevention) together with the FDA (Food and Drug Administration), the highest American authorities on the control of health and medicines.
CDC and FDA have reported the high risk of cerebral ischemia in vaccinated with the new bivalent boosters, confirming an alarm of danger compared to monovalent boosters launched as a preview by the medical doctors of the German University of Wuerzburg.
In the present case, the problem is detected in correlation to the now exceeded first dose and can justify the massacre from neurocerebral diseases reported by Gospa News in an exclusive investigation.
The research titled “Factors Associated with Stroke after COVID-19 Vaccination: A Statewide Analysis (link at footer of article)” refers only to Georgia and sees as its first signatory Fadi Nahab, Departments of Neurology & Pediatrics of Emory University, who was supported by Rana Bayakly and Moges Ido, Georgia Department of Public Health, and other Emory University physicians: Mary Elizabeth Sexton, Division of Infectious Diseases, Manet Lemuel-Clarke, Laura Henriquez, Srikant Rangaraju, Department of Neurology.
The study is also really important due to the fact that it crosses with another serious problem related to vaccines but not analyzed in this new publication.
These are the adverse reactions to experimental gene serums called Covid-breakthrough, i.e. when the pathogenic Spike protein of SARS-Cov-2 “breaches” the vaccine and triggers a Covid-19 disease that is not only highly symptomatic but in thousands of cases even lethal, as ascertained by the CDC itself in the USA but ignored in the EU and in Italy, where the phenomenon is minimized in the chaotic findings of the pharmacovigilance platform of the European Medicines Agency (Eudravigilance) and completely ignored in the quarterly dossiers of the Italian Medicines Agency.
It is in fact the only undesirable effect useful to explain how a “concomitant infection with Covid-19” can develop which according to doctors at Emory University increases even more the already high risks of neurocerebral pathologies, now reported by multiple studies and by the Gospa News’ exclusive investigation into the massacre caused by neurological disorders after the inoculation of the Covid vaccines.
Recently even Iraqi university doctors published alarming research on the Covid-breakthrough.
«The objective of our study was to evaluate baseline characteristics, COVID-19 infection and vaccine type and their association with stroke early after COVID-19 vaccination. Methods In a retrospective cohort study, we estimated the 21-day post vaccination incidence of stroke among COVID-19 first dose vaccine recipients. We linked the Georgia Immunization Registry with the Georgia Coverdell Acute Stroke Registry and the Georgia State Electronic Notifiable Disease Surveillance System data to assess the relative risk of stroke by vaccine type» write Nahab et al. in their study summary.
So here are their results highlighted in statistics:
«About 5 million adult Georgians received at least one COVID-19 vaccine from December 1, 2020 to February 28, 2022: 54% received BNT162b2, 41% mRNA-1273 and 5% Ad26.COV2.S. Those with concurrent COVID infection within 21 days post vaccine had an increased risk of ischemic (OR=8.00, 95% CI: 4.18, 15.31) and hemorrhagic stroke (OR=5.23, 95% CI: 1.11, 24.64) with no evidence for interaction between vaccine type and concurrent COVID-19 infection».
«The 21-day post vaccination incidence of ischemic stroke was 8.14, 11.14, and 10.48 per 100,000 for BNT162b2, mRNA-1273 and Ad26.COV2.S recipients, respectively. After adjusting for age, race, gender, and COVID-19 infection status there was a 57% higher risk (OR=1.57, 95% CI: 1.02, 2.42) for ischemic stroke within 21 days of vaccination associated with the Ad26.COV2.S vaccine compared to BNT162b2».
Translating the pharmacological code into names and companies: the adenoviral vector Jcovden (formerly COVID-19 Vaccine Janssen) of Janssen (Johnson & Johnson), in this pathology, is therefore even more dangerous than the mRNA biotechnology of Pfizer-Biontech’s Comirnaty vaccine.
«The early increased risk of both ischemic and hemorrhagic stroke in those vaccinated and with concurrent COVID-19 was independent of vaccine type. COVID-19 has been associated with an increased risk of acute ischemic stroke and intracerebral hemorrhage, and compared to stroke patients without infection, COVID-19 stroke patients tend to be younger and to have more severe strokes, a higher frequency of large artery occlusion and higher in-hospital mortality».
Could this also be the explanation for the many sudden illnesses among the under 20s filed without the necessary autopsies? The question is for “science profane” but it is a real issue…
«This suggests that COVID-19 infection leads to a much higher risk of stroke outweighing the risk of stroke associated with vaccine alone. COVID-19 vaccines using an adenoviral vector have been reported to have the rare occurrence of thrombotic thrombocytopenia including thrombosis of the cerebral veins. These cases have had positive heparin-PF4 HIT antibody ELISA tests in the absence of prior exposure to heparin. The FDA has reported that a causal relationship between Ad26.COV2.S vaccine and TTS is plausible, updating the EUA with a warning about rare clotting events after Ad26.COV2.S vaccination».
The doctors admit a notable limitation of the study «data was unavailable to determine if any of these early post-vaccination strokes were related to thrombotic thrombocytopenia». Obviously always for the usual reason of the absence, at the origin, of autopsies, even if only randomly.
«Although not all determinants of stroke, particularly comorbidities, were considered in this analysis, concurrent COVID-19 infection had the strongest association with early incidence of ischemic and hemorrhagic strokes after first dose COVID-19 vaccine recipients compared with those without infection. The Ad26.COV2.S vaccine appears to be associated with higher risk of early post-vaccination ischemic stroke than BNT162b2 vaccine further supporting the ACIP preferential recommendation for mRNA COVID-19 vaccines over the Ad26.COV2.S vaccine».
This bitter conclusion brings us back to the initial question on breach infections: shouldn’t gene or adenoviral serums have prevented the vaccinated from contracting a symptomatic or dangerous Covid-19?
A study conducted by the CDC in Utah (USA) had already established that those vaccinated with three doses were more at risk of contracting the Omicron variant in a symptomatic way, even severely.
We await an answer to these and other questions by the investigation launched by the Governor of Florida Ron DeSantis into the deaths related to the Covid vaccines and the one opened by the Public Prosecutor’s Office of Rome after the receipt of the documents of the Judge of the Court of Florence Susanna Zanda who reported the problem so that it could be analyzed in any implications of a criminal nature.
Fabio Giuseppe Carlo Carisio
© COPYRIGHT GOSPA NEWS
prohibition of reproduction without authorization
follow Gospa News on Telegram
MAIN SOURCES
MEDRXIV – Factors Associated with Stroke after COVID-19 Vaccination: A Statewide Analysis
GOSPA NEWS – WUHAN-GATES INQUIRIES
2 pensieri su ““Very High Risk of Stroke after Vaccines with Concurrent Covid”. Alert by Atlanta’s University study confirms the CDC-FDA one”